Email Sign-Up
 
34 results found
Filter Filters icon
Apply

Article

Trastuzumab deruxtecan

Trastuzumab deruxtecan (Enhertu) is an antibody drug conjugate approved to treat people with metastatic, HER2-positive, hormone receptor-negative breast cancer that has grown after at least two ...

Story 06/04/23

Enhertu continues to show good results

Two studies support use of trastuzumab deruxtecan for metastatic HER2-positive breast cancer 

Event

Ask the expert: Early-stage HER2-positive breast cancer

This free, 75-minute program is for those with early-stage HER2-positive breast cancer and will allow you to learn more about your diagnosis and ask questions of a medical expert while learning ...

Video 10/15/21

Ask the expert: Early-stage hormone receptor-positive, HER2-positive & triple-positive breast cancer

Article

Tucatinib

Tucatinib (Tukysa) is a tyrosine kinase inhibitor used to treat metastatic, HER2-postive breast cancer. It is given with another targeted therapy, trastuzumab (Herceptin), and the chemotherapy ...

Article

Trastuzumab

The medicine trastuzumab (Herceptin and biosimilars) is the most common medicine used to treat HER2-positive breast cancer. It is a monoclonal antibody, a medicine made in a lab that attacks a ...

Article

Pertuzumab

Pertuzumab (Perjeta) is a targeted therapy used to treat early-stage and metastatic HER2-positive breast cancer. Pertuzumab is a monoclonal antibody, a type of medicine made in a lab that targets ...

Article

Neratinib

Neratinib (Nerlynx) is a targeted therapy for people with HER2-positive breast cancer. It is the first medicine for people with HER2-positive breast cancer approved as extended therapy, meaning ...

Article

Margetuximab

Margetuximab (Margenza) is a medicine approved by the Food and Drug Administration to be given with chemotherapy to treat metastatic, HER2-positive breast cancer after treatment with at least two ...

Article

Lapatinib

Lapatinib (Tykerb) is targeted therapy in the dual tyrosine kinase inhibitor class. It is used with the chemotherapy pill capecitabine (Xeloda) or the aromatase inhibitor letrozole (Femara) to ...